VERSES AI Inc. Announces Pricing of Public Offering of Units
July 09, 2025 09:08 ET | Source: VERSES AI Inc. VANCOUVER, British…
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
VERSES Signs Soothsayer Analytics As First Genius Reseller and Fortune 500 Integrator
Agreement to accelerate global enterprise adoption of Genius through sales, training, certification,…